Using the standardized and validated MSD ELISA assay above, we confirmed that CXCL10, CCL2, and CCL18 were significantly elevated in the GC naïve DMD group relative to the healthy control group. The gene discussed is CCL2; the disease is Duchenne muscular dystrophy.